Clinical studies recruiting near Debrecen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Debreceni Egyetem Klinikai Kozpont · Eli Lilly and Company · NCT07218380 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Debreceni Egyetem - Orvos es Egeszsegtudomanyi Centrum (DEOE · Miltenyi Biomedicine GmbH · NCT04844866 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Borvo Clinic Kft · Amgen · NCT07037433 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Debreceni Egyetem Klinikai Kozpont ( Site 1601) · Merck Sharp & Dohme LLC · NCT07216703 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Phase 3 · University of Debrecen, Medical and Health Science Centre · Octapharma · NCT04918173 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Debreceni Egyetem Klinikai Kozpont · Pfizer · NCT05895786 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · University of Debrecen Clinical Center, Department of Urolog · UroGen Pharma Ltd. · NCT06774131 ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency
Phase 3 · Gyermekgyogyaszat, DE · Inozyme Pharma · NCT07473973 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Debreceni Egyetem Orvos-es Egészsegtudomanyi Centrum · Loxo Oncology, Inc. · NCT05254743 DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac
Phase 2 · Debreceni Egyetem Klinikai Központ · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Phase 2 · Debreceni Egyetem Klinikai Kozpont · Gesynta Pharma AB · NCT07260669 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Debreceni Egyetem Klinikai Kozpont ( Site 1112) · Merck Sharp & Dohme LLC · NCT06833073 Monitoring the Clinical and Immunological Effects of Microbiome Changes Following Severe Burn Injury
Phase N/A · University of Debrecen, Department of Anesthesiology and Int · Tamas Vegh, MD · NCT07329595 A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t
Phase 2 · Research Site · AstraZeneca · NCT07525375 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Debreceni Egyetem Altalanos Orvostudomanyi Kar Tudogyogyasza · Merck Sharp & Dohme LLC · NCT06623422 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · University of Debrecen Clinical Center, Clinic of Internal M · Takeda · NCT06499285 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0187 · Bristol-Myers Squibb · NCT03899155 A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Phase 3 · Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus · Hoffmann-La Roche · NCT07416604 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting
Phase N/A · DE Klinikai Központ, Tüdőgyógyászati Klinika · Chiesi Hungary Ltd. · NCT06678191 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Kenezy County Hospital · Ipsen · NCT06016842 Measuring Upper Airway Cross Sectional Areas During Residual Neuromuscular Blockade and After Reserval
Phase N/A · University of Debrecen · Tamas Vegh, MD · NCT06544980 The NEU-STIM Trial
NA · University of Debrecen · Leiden University Medical Center · NCT05942924 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · University of Debrecen Clinical Centre · Boehringer Ingelheim · NCT07472517 Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
Phase 3 · Debreceni Egyetem · Aleksander Krag · NCT05056220 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05939414

Look up another city

Look up another condition